https://sleuro.org/ciao-mondo/2026-05-26T16:22:54+02:00https://sleuro.org/elementor-86/2026-05-26T16:22:45+02:00https://sleuro.org/general-assembly-2026-key-decisions-and-next-steps/2026-05-26T16:22:38+02:00https://sleuro.org/lupus-nephritis-new-predictors-of-renal-outcomes-and-treatment-strategies/2020-12-18T12:04:00+01:00https://sleuro.org/lupus-nephritis-new-predictors-of-renal-outcomes-and-treatment-strategies-2/2020-12-18T12:03:47+01:00https://sleuro.org/improving-mortality-of-sle-patients-how-far-did-we-progress/2019-07-17T17:48:23+02:00https://sleuro.org/lupus-quality-of-care-unmet-needs-for-bridging-the-gaps-across-multiple-healthcare-settings/2019-07-17T17:49:42+02:00https://sleuro.org/is-sle-das-the-future-for-standardized-measure-of-disease-of-disease-activity-for-lupus-patients/2019-07-17T17:51:12+02:00https://sleuro.org/2019-update-of-the-eular-recommendations-for-the-management-of-systemic-lupus-erythematosus/2019-07-17T17:55:17+02:00https://sleuro.org/low-disease-activity-versus-remission-in-sle-is-it-ok-to-be-mediocre/2019-07-18T11:54:12+02:00https://sleuro.org/tubular-cell-and-keratinocyte-single-cell-transcriptomics-in-lupus-nephritis/2019-09-18T11:54:56+02:00https://sleuro.org/eular-recommendations-for-the-management-of-antiphospholipid-syndrome-in-adults/2019-09-18T11:55:39+02:00https://sleuro.org/2019-eular-acr-sle-classification-criteria-in-practice/2019-09-18T11:56:25+02:00https://sleuro.org/being-in-the-right-place-at-the-right-time-when-position-matters/2019-12-18T11:57:08+01:00https://sleuro.org/toward-a-novel-prediction-marker-in-sle/2019-12-18T11:57:41+01:00https://sleuro.org/trial-of-anifrolumab-in-active-systemic-lupus-erythematosus/2020-01-18T11:58:14+01:00https://sleuro.org/withdrawal-of-low-dose-prednisone-in-sle-patients-with-a-clinically-quiescent-disease-for-more-than-1-year-a-randomised-controlled-trial/2020-01-18T11:58:54+01:00https://sleuro.org/trial-in-anifrolumab-in-active-systemic-lupus-erythematosus/2020-05-18T11:59:50+02:00https://sleuro.org/over-a-course-of-46-years-clinical-presentation-of-lupus-nephritis-ln-has-become-less-severe-in-the-last-years-leading-to-a-better-long-term-renal-survival-the-indispensable-role-of-renal-biopsy/2020-05-18T12:00:30+02:00https://sleuro.org/lupus-nephritis-new-predictors-of-renal-outcomes-and-treatment-strategies-3/2020-12-18T12:01:43+01:00https://sleuro.org/interferon-lambda-function-in-a-tlr7-induced-lupus-model/2021-01-18T15:30:07+01:00https://sleuro.org/large-gwas-study-in-east-asian-individuals-with-sle/2021-01-18T15:41:25+01:00https://sleuro.org/mapping-systemic-lupus-erythematosus-heterogeneity-at-the-single-cell-level/2021-03-17T10:33:06+01:00https://sleuro.org/molecular-pathways-in-patients-with-systemic-lupus-erythematosus-revealed-by-gene-centred-dna-sequencing/2021-05-12T15:57:54+02:00https://sleuro.org/effectiveness-of-mycophenolate-voclosporin-combination-therapy-in-lupus-nephritis/2021-05-14T10:49:47+02:00https://sleuro.org/delineating-the-clinical-value-of-mmf-for-joint-manifestations/2021-07-13T15:48:43+02:00https://sleuro.org/quality-indicators-for-systemic-lupus-erythematosus/2021-08-11T17:18:56+02:00https://sleuro.org/towards-a-standardization-of-the-physican-global-assessment-pga-in-lupus/2022-06-30T09:55:31+02:00https://sleuro.org/3085-2/2022-07-14T16:53:40+02:00https://sleuro.org/hypomethylation-of-mir-17-92-cluster-in-lupus-t-cells-and-no-significant-role-of-genetic-factors-in-the-lupus-associated-dna-methylation-signature/2022-07-14T16:59:01+02:00https://sleuro.org/comment-on-trial-of-anti-bdca2-antibody-litifilimab-for-cutaneous-lupus-erythematosus/2022-08-02T20:45:27+02:00https://sleuro.org/lack-of-efficacy-of-ustekinumab-in-a-phase-3-randomised-controlled-trial-in-patients-with-systemic-lupus-erythematosus/2022-09-22T11:35:00+02:00https://sleuro.org/stopping-versus-continuing-maintenance-immunosuppressive-therapy-in-lupus-nephritis-at-2-3-years/2022-09-22T11:38:12+02:00https://sleuro.org/belimumab-use-during-pregnancy-a-summary-of-birth-defects-and-pregnancy-loss-from-belimumab-clinical-trials-a-pregnancy-registry-and-postmarketing-reports/2022-12-21T15:09:41+01:00https://sleuro.org/always-listen-to-our-haematology-colleagues/2023-01-09T12:13:40+01:00https://sleuro.org/global-epidemiology-of-systemic-lupus-erythematosus-a-comprehensive-systematic-analysis-and-modelling-study/2023-03-06T16:34:09+01:00https://sleuro.org/cutting-steroids-may-improve-patient-reported-quality-of-life-blocking-interferon-works-on-many-types-of-skin-lupus-even-when-all-other-therapies-have-failed/2023-05-19T10:11:24+02:00https://sleuro.org/blocking-interferon-works-on-many-types-of-skin-lupus-even-when-all-other-therapies-have-failed/2023-05-19T10:18:13+02:00https://sleuro.org/finally-an-anti-cd20-antibody-meeting-endpoints-in-randomized-trials/2026-04-28T11:28:50+02:00https://sleuro.org/a-high-burden-of-sle-risk-genes-is-associated-with-persistent-activation-of-the-interferon-system-in-patients-with-lupus/2026-05-25T17:53:04+02:00